Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 8-K Event Item 12 · Item 7
  2. 8-K Event Item 5 · Item 7
  3. 8-K Event Item 12 · Item 7
  4. DEF 14A Proxy Proxy Statement
  5. 10-K Report Annual Report
  6. 8-K Event Item 12 · Item 7
  7. 8-K Event Item 12 · Item 7
  8. 8-K Event Item 5 · Item 7
  9. 8-K Event Item 7 · Item 9
  10. 8-K Event Item 7 · Item 9
  11. DEF 14A Proxy Proxy Statement
  12. 10-K Report Annual Report
  13. DEF 14A Proxy Proxy Statement
  14. 10-K Report Annual Report
  15. 10-K/A Report 10-K/A
  16. DEF 14A Proxy Proxy Statement
  17. 10-K Report Annual Report
  18. 8-K Event Item 5 · Item 7
  19. 8-K Event Item 5 · Item 7
  20. 8-K Event Item 5 · Item 7

Page 16 of 17 · 336 filings